GuiZhou JingFeng Pharmaceutical Co., Ltd.
-
Founded in:
1990-10-22 -
Country:
China -
Address:
No. 158 Gaoxin Road, Wudang District, Guiyang City, Guizhou Province -
Tax NO.:
91520000214406110B -
Registered Funds:
730 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Naloxone hydrochloride |
This product is an opioid receptor antagonist, which has almost no pharmacological activity itself, but can competitively antagonize various opioid receptors and has a strong affinity for m receptors. It can completely or partially correct the central inhibitory effects of opioid substances, such as respiratory depression, sedation and hypotension; it has a wake-up effect on animals with acute ethanol poisoning; it is a pure opioid receptor antagonist and does not cause respiratory depression, psychotomimetic reactions or miotic reactions; there is no drug resistance, nor physiological or mental dependence.
More
This product is an opioid receptor antagonist, which has almost no pharmacological activity itself, but can competitively antagonize various opioid receptors and has a strong affinity for m receptors. It can completely or partially correct the central inhibitory effects of opioid substances, such as respiratory depression, sedation and hypotension; it has a wake-up effect on animals with acute ethanol poisoning; it is a pure opioid receptor antagonist and does not cause respiratory depression, psychotomimetic reactions or miotic reactions; there is no drug resistance, nor physiological or mental dependence. |
357-08-4 | 32 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Naloxone hydrochloride |
This product is an opioid receptor antagonist, which has almost no pharmacological activity itself, but can competitively antagonize various opioid receptors and has a strong affinity for m receptors. It can completely or partially correct the central inhibitory effects of opioid substances, such as respiratory depression, sedation and hypotension; it has a wake-up effect on animals with acute ethanol poisoning; it is a pure opioid receptor antagonist and does not cause respiratory depression, psychotomimetic reactions or miotic reactions; there is no drug resistance, nor physiological or mental dependence.
More
This product is an opioid receptor antagonist, which has almost no pharmacological activity itself, but can competitively antagonize various opioid receptors and has a strong affinity for m receptors. It can completely or partially correct the central inhibitory effects of opioid substances, such as respiratory depression, sedation and hypotension; it has a wake-up effect on animals with acute ethanol poisoning; it is a pure opioid receptor antagonist and does not cause respiratory depression, psychotomimetic reactions or miotic reactions; there is no drug resistance, nor physiological or mental dependence. |
357-08-4 | 32 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Golden Cherry Root |
|
0 | ||
| Spatholobi Caulis |
|
0 | ||
| jackpot |
|
0 | ||
| MAHONIAE CAULIS |
|
0 | ||
| ZANTHOXYLI RADIX |
|
0 | ||
| Andrographolide |
|
5508-58-7 | 6 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Salvia Root P.E Tanshinone IIA 20% |
|
0 | ||
| Riligustilide |
|
89354-45-0 | 0 | |
| Paeoniae Rubra |
|
0 | ||
| CARTHAMI FLOS |
|
0 | ||
| CYPERI RHIZOMA |
|
0 | ||
| Aucklandiae Radix |
|
0 | ||
| Hawthorn |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ligustrazine Hydrochloride |
It can promote blood circulation, remove blood stasis, dredge meridians and nourish the heart. It can resist platelet aggregation, dilate coronary arteries, reduce blood viscosity, accelerate the flow rate of red blood cells, improve microcirculation, and resist myocardial ischemia and myocardial infarction.
More
It can promote blood circulation, remove blood stasis, dredge meridians and nourish the heart. It can resist platelet aggregation, dilate coronary arteries, reduce blood viscosity, accelerate the flow rate of red blood cells, improve microcirculation, and resist myocardial ischemia and myocardial infarction. |
76494-51-4 | 12 | |
| Danshensu |
It can promote blood circulation, remove blood stasis, dredge meridians and nourish the heart. It can resist platelet aggregation, dilate coronary arteries, reduce blood viscosity, accelerate the flow rate of red blood cells, improve microcirculation, and resist myocardial ischemia and myocardial infarction.
More
It can promote blood circulation, remove blood stasis, dredge meridians and nourish the heart. It can resist platelet aggregation, dilate coronary arteries, reduce blood viscosity, accelerate the flow rate of red blood cells, improve microcirculation, and resist myocardial ischemia and myocardial infarction. |
76822-21-4 | 0 |